Nimesulide provides relief from primary dysmenorrhoea in adolescents & osteoarthritis. It’s a anti-inflammatory, non-steroidal drug. Nimusilide provides treatment for acute pain. But nimesulide has been drawn aside from the market because of its hepatic effects (risk of hepatatoxicity) on patients. In India this banned compound is still available easily. Because of the adverse reactions European countries & Israel has withdrawn nimesulide from market.